Bujold E - Search Results

1

First-Trimester Soluble fms-like Tyrosine Kinase 1 (sFlt-1) for the Prediction of Preterm Preeclampsia.

Fillion A, Boutin A, Giguère Y, Forest JC, Ghesquière L, Bujold E. Fillion A, et al. Among authors: bujold e. J Obstet Gynaecol Can. 2024 Dec 24;47(2):102753. doi: 10.1016/j.jogc.2024.102753. Online ahead of print. J Obstet Gynaecol Can. 2024. PMID: 39725027 Free article.

2

Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and meta-analysis.

Bujold E, Morency AM, Roberge S, Lacasse Y, Forest JC, Giguère Y. Bujold E, et al. J Obstet Gynaecol Can. 2009 Sep;31(9):818-826. doi: 10.1016/S1701-2163(16)34300-6. J Obstet Gynaecol Can. 2009. PMID: 19941706 Review.

3

Reproducibility of first trimester three-dimensional placental measurements in the evaluation of early placental insufficiency.

Bujold E, Effendi M, Girard M, Gouin K, Forest JC, Couturier B, Giguère Y. Bujold E, et al. J Obstet Gynaecol Can. 2009 Dec;31(12):1144-8. doi: 10.1016/s1701-2163(16)34375-4. J Obstet Gynaecol Can. 2009. PMID: 20085680

4

Prevention of adverse pregnancy outcomes with low-dose ASA in early pregnancy: new perspectives for future randomized trials.

Bujold E, Tapp S, Audibert F, Ferreira E, Forest JC, Rey E, Fraser WD, Chaillet N, Giguère Y. Bujold E, et al. J Obstet Gynaecol Can. 2011 May;33(5):480-483. doi: 10.1016/S1701-2163(16)34882-4. J Obstet Gynaecol Can. 2011. PMID: 21639969

5

Association between physical activity in early pregnancy and markers of placental growth and function.

Ferland S, Bujold E, Giguère Y, Girard M, Demers S, Forest JC. Ferland S, et al. Among authors: bujold e. J Obstet Gynaecol Can. 2013 Sep;35(9):787-792. doi: 10.1016/S1701-2163(15)30834-3. J Obstet Gynaecol Can. 2013. PMID: 24099443

6

Mid-trimester maternal serum AFP and hCG as markers of preterm and term adverse pregnancy outcomes.

Tancrède S, Bujold E, Giguère Y, Renald MH, Girouard J, Forest JC. Tancrède S, et al. Among authors: bujold e. J Obstet Gynaecol Can. 2015 Feb;37(2):111-6. doi: 10.1016/s1701-2163(15)30331-5. J Obstet Gynaecol Can. 2015. PMID: 25767942

7

Maternal Characteristics for the Prediction of Preeclampsia in Nulliparous Women: The Great Obstetrical Syndromes (GOS) Study.

Boutin A, Gasse C, Demers S, Giguère Y, Tétu A, Bujold E. Boutin A, et al. Among authors: bujold e. J Obstet Gynaecol Can. 2018 May;40(5):572-578. doi: 10.1016/j.jogc.2017.07.025. Epub 2017 Oct 24. J Obstet Gynaecol Can. 2018. PMID: 29079078

8

Does Low PAPP-A Predict Adverse Placenta-Mediated Outcomes in a Low-Risk Nulliparous Population? the Great Obstetrical Syndromes (GOS) Study.

Boutin A, Gasse C, Demers S, Blanchet G, Giguère Y, Bujold E. Boutin A, et al. Among authors: bujold e. J Obstet Gynaecol Can. 2018 Jun;40(6):663-668. doi: 10.1016/j.jogc.2017.08.047. Epub 2017 Dec 21. J Obstet Gynaecol Can. 2018. PMID: 29274935

9

First-Trimester Abdominal Adipose Tissue Thickness to Predict Gestational Diabetes.

Bourdages M, Demers MÉ, Dubé S, Gasse C, Girard M, Boutin A, Ray JG, Bujold E, Demers S. Bourdages M, et al. Among authors: bujold e. J Obstet Gynaecol Can. 2018 Jul;40(7):883-887. doi: 10.1016/j.jogc.2017.09.026. Epub 2018 Apr 30. J Obstet Gynaecol Can. 2018. PMID: 29724492

10

First Trimester Screening for Fetal Aneuploidies Using Placental Growth Factor: The Great Obstetrical Syndrome (GOS) Study.

Boutin A, Demers S, Gasse C, Giguère Y, Tétu A, Laforest G, Bujold E. Boutin A, et al. Among authors: bujold e. J Obstet Gynaecol Can. 2018 Aug;40(8):1044-1049. doi: 10.1016/j.jogc.2017.11.032. J Obstet Gynaecol Can. 2018. PMID: 30103877

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

331 results

Search Page

Filters